Skip to main content
Clinical Trials/NCT06217783
NCT06217783
Recruiting
Not Applicable

Ultrasound-guided Peripheral Intravenous Catheter Placement in an Oncologic Emergency Department - a Prospective, Randomized Controlled Trial of Catheter Lengths

M.D. Anderson Cancer Center1 site in 1 country400 target enrollmentMarch 27, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oncologic Complications and Emergencies
Sponsor
M.D. Anderson Cancer Center
Enrollment
400
Locations
1
Primary Endpoint
Safety and adverse events (AEs)
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

To learn about the effects of the length of the catheter on the failure and success rate of USIV placement.

Detailed Description

Primary Objectives: \- The rate of catheter failure, defined as removal of the catheter for any reason other than "Care Complete" (i.e. a composite of removal due to "infiltration," "leaking," "catheter damage," "occlusion"), by day 10. Secondary Objectives: 1. Time from catheter placement to removal (i.e. survival or dwell time). 2. Per catheter length rate of failure analysis 3. Rate of repeat catheterization 4. Rate of infection 5. Rate of thrombosis

Registry
clinicaltrials.gov
Start Date
March 27, 2024
End Date
December 1, 2027
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years old.
  • Provision of signed and dated informed consent form.
  • Predetermined to have difficult IV access necessitating USIV placement
  • Expected admission to hospital with anticipated stay \> 48 hours (per discussion with treating physician).

Exclusion Criteria

  • Expected/anticipated discharge disposition from the ACCC (per discussion with treating physician).
  • Inability to give informed consent.
  • Pregnant women.
  • Non-English speaking participants.

Outcomes

Primary Outcomes

Safety and adverse events (AEs)

Time Frame: Through study completion; an average of 1 year.

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE)

Study Sites (1)

Loading locations...

Similar Trials